Revenue
$21.8B
▲ 8.2% YoY
Net Income
$1.7B
▼ 1.6% YoY
EPS
$5.82
▼ 0.7% YoY
Cash
$641.0M
▼ 62.7% YoY
FY 2025 · As of 2025-09-30
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Feld Michael EVP, Chief Revenue Officer | Sell | Aug 26, 2026 | 165 | $188.49 | $31K | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Sell tax | Aug 20, 2026 | 1.0K | $0.00 | $0 | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Vest | Aug 13, 2026 | 43.3K | $167.25 | $7.24M | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Return | Aug 13, 2026 | 39.1K | $185.00 | $7.24M | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Sell | Aug 13, 2026 | 4.2K | $185.00 | $768K | Form 4 ↗ |
Goette Roland EVP and President, EMEA | Sell | Aug 11, 2026 | 2.4K | $180.84 | $441K | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Sell | Jul 27, 2026 | 75 | $157.13 | $12K | Form 4 ↗ |
Muhsin Bilal EVP & President Connected Care | Sell tax | Jul 2, 2026 | 1.9K | $0.00 | $0 | Form 4 ↗ |
Muhsin Bilal EVP & President Connected Care | Grant | Jul 1, 2026 | 14.3K | $0.00 | $0 | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Sell | Jun 26, 2026 | 75 | $152.80 | $11K | Form 4 ↗ |
Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sell | Jun 24, 2026 | 1.1K | $145.66 | $160K | Form 4 ↗ |
Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sell | Jun 10, 2026 | 1.1K | $151.48 | $167K | Form 4 ↗ |